Topic: Parkinson's disease
Takeda and AZ will team up on Parkinson’s candidate, Samsung Bioepis got nod for a Humira copycat and Daiichi Sankyo said AZ buyout is “not the fact.”
Adamas may be the first company to have won FDA approval for a medication to treat dyskinesia in Parkinson’s patients.
Klick Health's Klick Labs created a programmable device that simulates Parkinson's disease tremors in a bid to create empathy and study its effect on patients.
An add-on Parkinson’s med already available in various countries throughout Europe will soon make its way to U.S. patients.
Intec Pharma, maker of the Accordian Pill delivery platform, secured a $5.2 million grant from the Israeli government to support late-stage R&D for its Parkinson’s candidate, which makes use of the oral technology.
Researchers in Mexico have developed a nanogel capable of regenerating brain tissue when injected into the organ to treat such neurogenerative diseases as Parkinson’s and Alzheimer’s.
When Parkinson's disease patients start taking new meds, doctors go on the lookout for the usual side effects: dizziness, nausea, and the like. But according to a new study, they need to think weird, too. The risk of compulsive behavior--gambling, shopping, sex--is much higher than previously thought.